Evidence map›Paper›PMID 30028071›Full record

ArticleAging cell2018

Nrf2 stabilization prevents critical oxidative damage in Down syndrome cells.

Emiliano Zamponi, Nahuel Zamponi, Pinar Coskun, Gonzalo Quassollo, Alfredo Lorenzo, Sergio A Cannas, Gustavo Pigino, Dante R Chialvo, Katheleen Gardiner, Jorge Busciglio and 1 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Effects of Resistance Training in Muscle Mass and Markers of Muscle Damage in Adults with Down Syndrome.International journal of environmental research and public health · 2021
    Trial
  2. Article
  3. Review
  4. Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Review
  5. Oxidative Stress and Down Syndrome: A Systematic Review.Antioxidants (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. The Role of Oxidative Stress in Trisomy 21 Phenotype.Cellular and molecular neurobiology · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Emiliano ZamponiInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Cordoba, Argentina.
Nahuel ZamponiDepartment of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York.
Pinar CoskunDepartment of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders and Center for the Neurobiology of Learning and Memory, University of California Irvine, Irvine, California.
Gonzalo QuassolloInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Cordoba, Argentina.
Alfredo LorenzoInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Cordoba, Argentina.
Sergio A CannasInstituto de Física Enrique Gaviola (IFEG-CONICET), FAMAFyC, UNC, Cordoba, Argentina.
Gustavo PiginoInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Cordoba, Argentina.
Dante R ChialvoCenter for Complex Systems and Brain Sciences (CEMSC3), UNSAM, San Martin, Argentina.
Katheleen GardinerDepartment of Pediatrics, Linda Crnic Institute for Down Syndrome, University of Colorado Denver School of Medicine, Aurora, Colorado.
Jorge BusciglioDepartment of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders and Center for the Neurobiology of Learning and Memory, University of California Irvine, Irvine, California.
Pablo HelgueraInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Cordoba, Argentina.ORCID 0000-0003-0863-8685
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversity of California, Irvine · USCornell University · USNational University of General San Martín · ARUniversity of Colorado Denver · US

Funding

UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
Combinational pharmacotherapies for neuronal abnormalities in Down syndromeR21HD076456 · NICHD · UNIVERSITY OF COLORADO DENVER · PI BUSCIGLIO, JORGE A, GARDINER, KATHELEEN · 2015 to 2016
$438k
NIA NIH HHS P50 AG016573NICHD NIH HHS R21 HD076456
6 · The paper itself

Abstract

Mounting evidence implicates chronic oxidative stress as a critical driver of the aging process. Down syndrome (DS) is characterized by a complex phenotype, including early senescence. DS cells display increased levels of reactive oxygen species (ROS) and mitochondrial structural and metabolic dysfunction, which are counterbalanced by sustained Nrf2-mediated transcription of cellular antioxidant response elements (ARE). Here, we show that caspase 3/PKCδdependent activation of the Nrf2 pathway in DS and Dp16 (a mouse model of DS) cells is necessary to protect against chronic oxidative damage and to preserve cellular functionality. Mitochondria-targeted catalase (mCAT) significantly reduced oxidative stress, restored mitochondrial structure and function, normalized replicative and wound healing capacity, and rendered the Nrf2-mediated antioxidant response dispensable. These results highlight the critical role of Nrf2/ARE in the maintenance of DS cell homeostasis and validate mitochondrial-specific interventions as a key aspect of antioxidant and antiaging therapies.

Indexed as

Oxidative StressAnimalsAntioxidantsCaspase 3CatalaseCell ProliferationCell SurvivalCytoprotectionDown SyndromeFibroblastsHEK293 CellsHumansMice, Inbred C57BLMitochondriaModels, BiologicalNF-E2-Related Factor 2AntioxidantsCaspase 3CatalaseNF-E2-Related Factor 2Protein Kinase C-deltaDown syndromeDp16mitochondrial catalaseNrf2oxidative stressPKCδ

Identifiers

PMID30028071
PMCPMC6156351
OpenAlexW2883526689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.